Clinical Trials Browser

Terminated × NIH × Unspecified Adult Solid Tumor, Protocol Specific × Clear all

NCT00112684 2014-02-24

Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00436579 2014-02-24

Sorafenib in Treating Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00701298 2014-02-24

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00369200 2013-12-11

AFP464 in Treating Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00012194 2013-07-09

7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00009958 2013-05-16

Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00066625 2013-02-01

Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00010205 2013-01-25

Benzoylphenylurea in Treating Patients With Advanced Cancer

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00030693 2013-01-24

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00049088 2013-01-24

Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00086970 2013-01-24

Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00028561 2013-01-17

BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific